The steroid receptor co-factor AIBI promotes tamoxifen resistance and may provide a diagnostic marker for early implementation of aromatase inhibitor treatment

Project Details

StatusFinished
Effective start/end date1/04/0630/04/08

Funding

  • UK central government bodies/local authorities, health and hospital authorities: £24,615.00